Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.
Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, de Andrés R, Arroyo-Olivares R, Fuentes-Jimenez F, Muñoz-Torrero JS, Cepeda J, Aguado R, Alvarez-Baños P, Casañas M, Dieguez M, Mañas MD, Rubio P, Argueso R, Arrieta F, Gonzalez-Bustos P, Perez-Isla L, Mata P; SAFEHEART investigators.
Alonso R, et al. Among authors: zambon d.
J Clin Lipidol. 2021 Jul-Aug;15(4):584-592. doi: 10.1016/j.jacl.2021.04.011. Epub 2021 May 7.
J Clin Lipidol. 2021.
PMID: 34052174